Faxitron Bioptics

What Faxitron Bioptics does

Faxitron Bioptics, founded in 1993 and headquartered in Tucson, Arizona, is a medical device company specializing in digital specimen radiography systems for pathology laboratories. The company's flagship product, the Faxitron Path Specimen Radiography System (also marketed as PathVision), uses a large-format 23 x 29 cm CMOS detector combined with a wide 20-100kV energy range and up to 6X geometric magnification to deliver high-resolution imaging of pathology specimens — including breast tissue slides, intact mastectomies, bones, and fetal remains. The system features automatic exposure control (AEC) and point-of-care placement design for one-button operation, targeting reduced re-cuts and faster reporting in pathology workflows.

Since its acquisition by Hologic, Inc. (NASDAQ: HOLX) in 2017, Faxitron Bioptics has operated as a product line within Hologic's breast health portfolio rather than as an independent entity. The product is sold as capital equipment to hospital pathology labs, breast health centers, and medical research laboratories through Hologic's enterprise direct sales organization, with US customers able to order through Hologic's iStore online platform. Revenue mechanics are based on one-time hardware sales, complemented by service and support contracts, with marketing handled primarily through Hologic's corporate website, datasheets, training materials, and presence at medical conferences.

The company's 51-100 employee headcount, combined with Hologic's global distribution footprint spanning North America, Europe, and Asia Pacific, positions Faxitron as a niche but distribution-rich player in the digital specimen radiography niche, with particular strength in breast pathology applications.

Name

Faxitron Bioptics

Legal name

Hologic, Inc.

Website

https://faxitron.com

Company type

Public

Founded year

1993

Operating status

Operating

Headcount range

51–100 employees

Short description

Faxitron Bioptics designs and sells digital specimen radiography systems for hospital pathology labs and breast health centers, using CMOS detector technology to image tissue samples. Acquired by Hologic in 2017, it now operates as a product line within Hologic's breast health portfolio.

Ownership category

akta.pro rank

Product category

Digital Specimen Radiography Equipment

NAICS

Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Mammography & Breast Imaging Systems (HLAHABAF)

akta.pro secondary industry

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

Keywords

• Specimen radiography systems
• Digital pathology imaging
• Breast tissue radiography
• CMOS detector imaging
• Pathology lab equipment

Headquarters

HQ city

Tucson

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations

Revenue model

1. Medical Device Hardware Sales: One-time capital equipment sales of Faxitron Path specimen radiography systems to hospital pathology departments and laboratory settings. Revenue generated from initial hardware purchase, with potential for service and support contracts.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Faxitron Bioptics designs, manufactures, and sells the Faxitron Path Specimen Radiography System (also marketed as PathVision), a digital pathology imaging device used by hospital pathology labs and breast health centers. The system provides high-resolution digital imaging of surgical and biopsy specimens—including breast tissue, mastectomies, bones, and fetal remains—using a large-format CMOS detector with up to 6X geometric magnification and automatic exposure control for point-of-care use.

Product overview

Faxitron Bioptics, now part of Hologic, offers specimen radiography and digital pathology solutions. The core product is the Faxitron® Path Specimen Radiography System (also known as PathVision™), which provides high-resolution imaging for pathology specimens with up to 6X geometric magnification and automatic exposure control. This integrates with the FaxitronPath® Digital Pathology System for complete digital pathology workflow solutions, enabling pathologists to achieve greater efficiency and exceptional patient care through immediate access to imaging and reporting at the point of care.

Differentiator

Problem solved

Functional benefit

Products and services

• Faxitron Path Specimen Radiography System A specimen radiography system for hospital pathology departments providing immediate high-resolution digital imaging of tissue samples. Features a 23 x 29 cm CMOS detector, up to 6X geometric magnification, wide 20-100kV energy range, one-button operation with Automatic Exposure Control, and accommodates breast tissue slides, intact mastectomies, bones, and fetal remains.

Quantifiable outcome

• Up to 6X geometric magnification for detection of smallest calcifications
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Philips Healthcare: Imaging incumbent serving hospital radiology departments with mammography and diagnostic X-ray systems; competes with Faxitron Path for capital equipment share within the same hospital networks.
• GE HealthCare: Global imaging incumbent offering mammography, ultrasound and digital radiography equipment to the same hospital radiology and pathology buyers. Overlaps with Faxitron Path in breast imaging workflows at the hospital system level.
• Hologic: Parent company and broader women's-health imaging incumbent. Hologic's mammography, biopsy and breast surgery franchises share the same hospital pathology and breast center buyers that Faxitron Path serves.
• Roche Digital Pathology (Ventana): Digital pathology and tissue diagnostics franchise of Roche serving hospital pathology labs with whole-slide imaging and companion diagnostic workflows that interface with specimen imaging.
• Leica Biosystems (Danaher): Major pathology workflow vendor (whole-slide imaging, tissue processors, staining) that overlaps with Faxitron Path at the pathology department level and competes for the digital pathology budget.
• Fujifilm Healthcare: Mammography and X-ray imaging vendor with breast health and digital radiography offerings that compete for the same hospital capital budgets as Faxitron Path.
• Siemens Healthineers: Broad-line imaging and diagnostics vendor with mammography and X-ray portfolios targeting the same hospital procurement and radiology-pathology stakeholders as Faxitron Path.

Emerging players

• Hamamatsu Photonics: Manufacturer of high-resolution digital slide scanners and detectors used in pathology imaging; comparable to Faxitron Path at the imaging-sensor and digital pathology workflow layer.
• 3DHISTECH: Digital pathology scanner and software vendor serving hospital and research pathology labs; competes with FaxitronPath digital pathology software workflow around whole-slide imaging and case management.

Direct peers

• Kubtec: Closest direct competitor in cabinet specimen radiography for breast and pathology use. Kubtec's XPERT systems compete head-to-head with the Faxitron Path on field of view, magnification and digital imaging of excised tissue specimens.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/faxitron
• YouTubeyoutube.com/user/hologic250
• Facebookfacebook.com/Faxitron
• LinkedInlinkedin.com/company/hologic
• Instagraminstagram.com/hologic

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Faxitron Bioptics